By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Matrix Laboratories Limited 

1-1-151/1, 4th Floor
Sai Ram Towers
Alexander Road

Secunderabad    500 003  India
Phone: 91-40-27700363 or 91-40-55327722 Fax: 91-40-27700343


SEARCH JOBS


Industry
Pharmaceutical

Segment
Research





Company News
Matrix Laboratories Limited (MAXL.BO) Completes Name Change to Mylan Laboratories Inc. (MYL) 10/19/2011 11:35:30 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Gets Tentative FDA Approval for AIDS Drug 9/20/2011 6:55:57 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives Approval for Generic Version of Aricept(R) Tablets 6/7/2011 11:34:39 AM
Mylan Inc. (MYL) to Rebrand Matrix Laboratories Limited (MAXL.BO) 5/27/2011 6:37:43 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg 3/10/2011 6:51:27 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives Approval for Generic Version of Neurontin(R) Capsules 2/28/2011 10:00:45 AM
Tibotec Pharmaceuticals Ltd Signs Multiple Agreements With Generic Manufacturers, Including Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO), Aspen Pharmacare Holdings and Hetero Drugs to Provide Access to New HIV Treatment 1/27/2011 8:00:52 AM
Another Gastroesophageal Reflux Disease Drug Goes Generic by Matrix Laboratories Limited (MAXL.BO) 1/26/2011 6:21:00 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives Tentative FDA Approval Under PEPFAR for Lamivudine and Zidovudine Tablets, 30 mg/60 mg 1/20/2011 7:17:10 AM
Mylan Inc. (MYL) Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories Limited (MAXL.BO)' New Drug Application (NDA) for Efavirenz Tablets 12/22/2009 7:04:11 AM
123
//-->